UKHSA (UK) · Jul 30, 2026
Guidance: Pre-release access lists: Tuberculosis in England national quarterly reports
Lists of those receiving pre-release access to UK Health Security Agency Tuberculosis in England: national quarterly reports.
Latest medical news · page 21
The latest headlines across every section, pulled from official and open-access sources.
UKHSA (UK) · Jul 30, 2026
Guidance: Pre-release access list: Reports of cases of TB to UK enhanced tuberculosis surveillance systems 2000 to 2024
Lists of those receiving pre-release access to UK Health Security Agency Tuberculosis annual data
UKHSA (UK) · Jul 30, 2026
Official Statistics: Tuberculosis in England: national quarterly reports
The latest quarterly reports of provisional data for tuberculosis (TB) notifications in England.
UKHSA (UK) · Jul 30, 2026
Research: Mycoplasma genitalium antimicrobial resistance surveillance (MARS)
Data on the latest findings relating to antimicrobial resistance in Mycoplasma genitalium from specimens collected in sexual health clinics across England.
UKHSA (UK) · Jul 30, 2026
Official Statistics: Reports of cases of TB to UK enhanced tuberculosis surveillance systems, 2000 to 2025
Official statistics from the UK enhanced tuberculosis surveillance systems, annual report: 2000 to 2025.
UKHSA (UK) · Jul 30, 2026
Official Statistics: Reports of cases of TB to UK enhanced tuberculosis surveillance systems: 2000 to 2024
Official statistics from the UK enhanced tuberculosis surveillance systems, annual report: 2000 to 2024.
UKHSA (UK) · Jul 30, 2026
Research: Pertussis immunisation in pregnancy: vaccine coverage (England)
Vaccine uptake data and commentary about the pertussis (whooping cough) vaccination programme for pregnant women.
Fierce Biotech · Jul 30, 2026
Labcorp posts higher Q2 earnings on strength of diagnostics, lab services; adjusts full-year guidance
Labcorp continues to power along as it posts strong quarterly earnings led by growth in its diagnostics and lab services and triggering the medtech to raise its full-year guidance.
MHRA (UK) · Jul 30, 2026
Guidance: London Region I MHRA Regulatory Sandbox: call for expressions of interest
Expressions of interest are invited from AI-enabled medical device manufacturers and NHS provider organisations interested in participating in the London Region I MHRA Regulatory Sandbox.
Fierce Biotech · Jul 30, 2026
Takeda scraps another phase 2 celiac disease therapy, narrowing pipeline to one
Takeda has dropped another celiac disease therapy from its phase 2 pipeline, leaving the company with just one shot at treating the condition.
DHSC (UK) · Jul 30, 2026
Guidance: WorkWell
Information on WorkWell for local systems partnerships.
Fierce Biotech · Jul 30, 2026
GSK pens $110M biological datasets pact with AI biotech Relation
GSK is boosting its AI chops with a new deal worth up to $110 million with Relation.
Fierce Biotech · Jul 30, 2026
Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
Sanofi's new CEO Belén Garijo opened up for the first time about her strategy to reverse a trend of clinical setbacks, including dumping Regeneron-partnered IL-33 candidate itepekimab.
CDC Travel Notices · Jul 30, 2026
Level 1 - Global Dengue
Dengue is a year-round risk in many parts of the world, with outbreaks commonly occurring every 2–5 years. Travelers to risk areas should prevent mosquito bites. Country List : Colombia, Samoa, Vietnam, New Caledonia (France), Maldives, Bolivia, Tonga, Cambodia, Kenya, Malaysia, Sri Lanka Country List : Colombia, Samoa, Vietnam, New Caledonia (France), Maldives, Bolivia, Tonga, Cambodia, Kenya, Malaysia, Sri Lanka
CDC Travel Notices · Jul 30, 2026
Level 2 - Chikungunya in Costa Rica
There is an outbreak of chikungunya in northwest Costa Rica. You can protect yourself by preventing mosquito bites.
FDA MedWatch · Jul 30, 2026
Convenience Kit Correction: Argon Medical Issues Correction for Convenience Kits Containing Spectra Medical Device Lidocaine Ampules
Argon Medical is correcting affected convenience kits by removing included Spectra Medical Devices Lidocaine Ampules.
Fierce Biotech · Jul 30, 2026
Boston Scientific cuts guidance again after unveiling restructuring plan
Boston Scientific is cutting its financial guidance for the second quarter in a row as it gears up for a tough six months ahead.
Fierce Biotech · Jul 30, 2026
J&J pays Sail $785M, charting course to possible in vivo CAR-T buyout
Johnson & Johnson is cruising deeper into in vivo CAR-T waters, paying $785 million upfront to strike a deal that gives it the option to acquire Sail Biomedicines.
JAMA Network Open · Jul 30, 2026
Geographic Clustering in Childhood Vaccination
Public Health
JAMA Network Open · Jul 30, 2026
Adiposity in Bone Health—Moving Away From BMI
Oncology
JAMA Network Open · Jul 30, 2026
Trends in Disability Compensation Benefits Among Military Veterans in the US, 2010 to 2024
This cohort study evalutes trends in US Department of Veterans Affairs disability compensation receipt and benefit amounts from 2010 to 2024 and their association with sociodemographic characteristics and disability type.
JAMA Network Open · Jul 30, 2026
Global Disparities in Current Clinical Trials in Cervical Cancer
This cross-sectional study examines the global landscape of cervical cancer clinical trials and assesses how closely trial activity matches global disease burden.
JAMA Network Open · Jul 30, 2026
Federal Housing Assistance and Survival in Older Adults With NSCLC
This cohort study investigates associations between federal housing assistance, receipt of guideline-concordant treatment, and survival among Medicare beneficiaries with non–small cell lung cancer (NSCLC).
JAMA Network Open · Jul 30, 2026
Geographic Variation in Measles Vaccine Coverage in School-Aged Children
This cohort study assesses the variation in measles-containing vaccine coverage at the county census tract level among children aged 7 years in Northern California.